DHR

Danaher Corporation

230.25

USD

+3.91

+1.73%

Nov 06, 15:59 UTC -5

Closed

After-Market

228.37

-1.88

-0.82%

Danaher Corporation (DHR) Earnings

DHR Earnings Reports

Positive Surprise Ratio

DHR beat 40 of 43 last estimates.

93%

Next Report

Date of Next Report

Jan 26, 2027

Estimate for Q4 26 (Revenue/ EPS)

$7.57B

$2.50

Implied change from Q3 26 (Revenue/ EPS)

+15.55%

+18.48%

Implied change from Q4 25 (Revenue/ EPS)

+10.76%

+12.11%

Danaher Corporation earnings per share and revenue

On Oct 21, 2026, DHR reported earnings of 2.11 USD per share (EPS) for Q3 26, beating the estimate of 1.93 USD, resulting in a 8.99% surprise. Revenue reached 6.55 billion, compared to an expected 6.62 billion, with a -1.07% difference. The market reacted with a +4.29% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of 2.50 USD, with revenue projected to reach 7.57 billion USD, implying an increase of 18.48% EPS, and increase of 15.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Natera, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.29

Actual

-$0.39

Surprise

-30.65%

Viatris Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.64

Actual

$0.71

Surprise

+9.31%

Solventum Corporation

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.38

Actual

$1.45

Surprise

+5.02%

Concentra Group Holdings Parent, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.44

Actual

$0.52

Surprise

+16.88%

Sonida Senior Living, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.54

Actual

-$0.65

Surprise

-19.11%

Nutex Health Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$5.82

Actual

$5.71

Surprise

-1.93%

Omada Health, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.01

Actual

$0.17

Surprise

+900.00%

CryoPort, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.17

Actual

-$0.25

Surprise

-38.97%

Shoulder Innovations, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.34

Surprise

+32.57%

Biodesix, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.76

Actual

-$0.75

Surprise

+1.77%

FAQ

What were Danaher Corporation's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Danaher Corporation reported EPS of $2.11, beating estimates by 8.99%, and revenue of $6.55B, -1.07% below expectations.

How did the market react to Danaher Corporation's Q3 2026 earnings?

The stock price moved up 4.29%, changed from $224.24 before the earnings release to $233.86 the day after.

When is Danaher Corporation expected to report next?

The next earning report is scheduled for Jan 26, 2027.

What are the forecasts for Danaher Corporation's next earnings report?

Based on -- analysts, Danaher Corporation is expected to report EPS of $2.50 and revenue of $7.57B for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.